Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReact Group Regulatory News (REAT)

Share Price Information for React Group (REAT)

Share Price is delayed by 15 minutes
Get Live Data
45.50    0.00 (0.00%)
Bid:
44.00
Ask:
47.00
Spread: 3.00 (6.818%)
Market Cap: £10.75m
REAT Live PriceLast checked at - London Stock Exchange

Intraday React Group Share Chart

Director/PDMR Shareholding

13 Jul 2022 07:00

RNS Number : 2467S
React Group PLC
13 July 2022
 

 

REACT Group plc

("REACT" or the "Company")

 

Director Dealings

 

The Board of REACT (AIM: REAT), the leading specialist cleaning, hygiene and decontamination company, announces that Executive Chairman Mark Braund has purchased 951,476 ordinary shares of 0.25 pence each in the Company ("Ordinary Shares") at a price of 1.05 pence per share on 12 July 2022. As a result, Mark now holds 1,725,731 Ordinary Shares, equivalent to 0.16% of the Company's issued share capital.

 

The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.

 

For further information:

 

REACT Group Plc

Shaun Doak, Chief Executive Officer

Andrea Pankhurst, Chief Financial Officer

Mark Braund, Chairman

Tel: +44 (0) 1283 550 503

Singer Capital Markets

(Nominated Adviser / Broker)

 

Will Goode / Amanda Gray (Corporate Finance)

Rachel Hayes (Corporate Broking)

Tel: +44 (0) 207 496 3000

IFC Advisory

(Financial PR / IR)

Graham Herring / Zach Cohen

 

Tel: +44 (0) 20 3934 6630

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Braund

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

REACT Group PLC

b)

LEI

213800H54C4GOFN7MO32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.25 pence each

GB00BZ2JBG28

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

1.05 pence

951,476

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

12 July 2022

f)

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUUUWRUOUBAAR
Date   Source Headline
17th Jun 202611:56 amRNSDirector/PDMR Shareholding
19th May 202611:23 amRNSInvestor Presentation via Investor Meet Company
19th May 20267:00 amRNSInterim Results and Investor Presentation
13th May 20265:17 pmRNSDirector/PDMR Shareholding
15th Apr 202610:25 amRNSDirector/PDMR Shareholding
31st Mar 20267:28 amRNSAGM Statement
27th Mar 202610:16 amRNSNotice of AGM
13th Feb 20264:22 pmRNSHolding(s) in Company
13th Feb 20264:13 pmRNSHolding(s) in Company
13th Feb 20263:03 pmRNSDirector/PDMR Shareholding
13th Feb 20261:11 pmRNSDirector/PDMR Shareholding
12th Feb 20265:18 pmRNSHolding(s) in Company
12th Feb 202611:35 amRNSHolding(s) in Company
11th Feb 20264:18 pmRNSHolding(s) in Company
10th Feb 20264:33 pmRNSPDMR Dealings
5th Feb 20267:00 amRNSFinal Results
2nd Feb 20267:00 amRNSNotice of Results
19th Jan 20263:37 pmRNSHolding(s) in Company
13th Jan 20262:56 pmRNSDirector/PDMR Shareholding
9th Jan 20263:03 pmRNSHolding(s) in Company
2nd Jan 202611:15 amRNSDirector/PDMR Shareholding
15th Dec 20254:28 pmRNSDirector/PDMR Shareholding
14th Nov 20253:43 pmRNSHolding(s) in Company
28th Oct 20257:00 amRNSTrading Update
16th Oct 20255:18 pmRNSDirector/PDMR Shareholding
16th Sep 20259:13 amRNSDirector/PDMR Shareholding
14th Aug 202511:31 amRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSContract Wins
16th Jul 20252:38 pmRNSShare Incentive Plan
15th Jul 20251:53 pmRNSHolding(s) in Company
27th May 20257:00 amRNSInterim Results & Trading Update
19th May 20258:27 amRNSHolding(s) in Company
29th Apr 202512:30 pmRNSHolding(s) in Company
25th Apr 20252:35 pmRNSHolding(s) in Company
27th Mar 20251:15 pmRNSResult of AGM
27th Mar 20257:00 amRNSAGM Statement
19th Mar 20253:01 pmRNSDirector/PDMR Shareholding
19th Mar 20251:15 pmRNSHolding(s) in Company
6th Mar 202512:09 pmRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSNotice of AGM
12th Feb 20253:34 pmRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNS-RContract Win
30th Jan 20251:59 pmRNSHolding(s) in Company
29th Jan 202511:11 amRNSInvestor Presentation
29th Jan 20257:00 amRNSFinal Results
28th Jan 20256:07 pmRNSHolding(s) in Company
21st Jan 20252:00 pmRNSHolding(s) in Company
8th Nov 20245:12 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSExercise of Options & Total Voting Rights
30th Oct 20243:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.